The Extracorporeal Membrane Oxygenation Machine market is witnessing substantial growth driven by the rising incidence of severe respiratory and cardiac failures across developed and emerging economies. The market outlook remains positive as healthcare providers increasingly adopt advanced life-support technologies for critical care management. Continuous technological innovations in oxygenation systems, coupled with enhanced patient monitoring capabilities, are contributing to improved clinical outcomes and greater adoption in intensive care units.
The integration of digital control systems and automation in ECMO devices has further optimized efficiency and reduced operational complexity, supporting their expanding use. Additionally, the rising prevalence of cardiovascular diseases, increasing cases of acute respiratory distress syndrome, and a growing number of cardiac surgeries are reinforcing demand for ECMO systems.
| Metric | Value |
|---|---|
| Extracorporeal Membrane Oxygenation Machine Market Estimated Value in (2025 E) | USD 608.4 million |
| Extracorporeal Membrane Oxygenation Machine Market Forecast Value in (2035 F) | USD 944.8 million |
| Forecast CAGR (2025 to 2035) | 4.5% |
Supportive healthcare investments, favorable reimbursement policies, and growing awareness about extracorporeal life support have accelerated equipment upgrades and hospital installations As healthcare systems prioritize advanced critical care infrastructure, the ECMO market is expected to experience sustained growth over the coming years.
The market is segmented by Product, Service Type, Component, Modality, and Patient Type and region. By Product, the market is divided into Static Devices, Portable Devices, and Software. In terms of Service Type, the market is classified into Application, Middleware, and Infrastructure. Based on Component, the market is segmented into Oxygenators, Pumps, Controllers, Cannula, and Accessories. By Modality, the market is divided into Veno-Venous, Veno-Arterial, and Arterio-Venous. By Patient Type, the market is segmented into Adults, Pediatrics, and Neonates. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The static devices product segment is projected to hold 45.00% of the Extracorporeal Membrane Oxygenation Machine market revenue share in 2025, making it the leading product category. This dominance is driven by the reliability, stability, and continuous operation that static ECMO systems provide during prolonged critical care treatment. These devices are designed for stationary hospital environments, ensuring consistent oxygenation and circulatory support for patients with severe respiratory or cardiac conditions.
The integration of software-based monitoring and automated control functions has improved patient safety and treatment precision, further reinforcing adoption. Increasing preference for high-performance ECMO systems capable of long-duration operation has supported the strong presence of static devices in tertiary healthcare facilities.
The growing number of cardiac centers and intensive care units equipped with permanent ECMO installations is further contributing to the segment’s expansion Continuous advancements in flow regulation, system integration, and ease of maintenance have made static devices the preferred option for high-acuity patient management.
The application segment is anticipated to account for 50.00% of the Extracorporeal Membrane Oxygenation Machine market revenue share in 2025, positioning it as the leading area of use. This growth has been influenced by the broadening clinical applications of ECMO systems in both respiratory and cardiac support. Increasing use of ECMO in cases of acute respiratory failure, cardiogenic shock, and post-cardiac surgery recovery has expanded its clinical relevance.
The segment’s growth is reinforced by improved survival rates and the proven efficacy of ECMO as a bridge therapy for transplant and recovery. Enhanced medical training, better patient selection, and technological innovations in control interfaces have increased procedural success and reduced complications.
Hospitals are increasingly integrating ECMO as part of comprehensive critical care protocols, driving utilization across emergency and intensive care units The growing global burden of respiratory and cardiovascular diseases, combined with rising healthcare investments in life support systems, continues to strengthen the application segment’s leading position.
The oxygenators component segment is expected to hold 30.00% of the Extracorporeal Membrane Oxygenation Machine market revenue share in 2025, making it a key driver of overall system performance. This growth is attributed to the crucial role oxygenators play in maintaining efficient gas exchange, ensuring optimal oxygenation and carbon dioxide removal during ECMO therapy. Technological advancements in membrane materials and coating technologies have enhanced biocompatibility and reduced blood trauma, improving patient outcomes.
Continuous improvements in design have also increased durability and minimized resistance, supporting longer operational life and greater reliability in clinical use. The demand for high-efficiency oxygenators is further fueled by the increasing complexity of ECMO procedures and the need for consistent oxygen transfer rates.
The segment has also benefited from hospital initiatives to upgrade to modular ECMO systems that allow easy replacement and maintenance of oxygenators As medical facilities continue to prioritize safety, performance, and cost efficiency, the oxygenator component segment remains vital to the ECMO market’s advancement.
The table below compares the compound annual growth rate (CAGR) for the global extracorporeal membrane oxygenation machine market from 2025 to 2025 during the first half of the year. This overview highlights key changes and trends in revenue growth, offering valuable insights into market dynamics.
H1 covers January to June, while H2 spans July to December. In the first half (H1) of the decade from 2025 to 2035, the business is predicted to surge at a CAGR of 5.5%, followed by a slightly lower growth rate of 4.9% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 5.5% (2025 to 2035) |
| H2 | 4.9% (2025 to 2035) |
| H1 | 4.5% (2025 to 2035) |
| H2 | 4.2% (2025 to 2035) |
Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to decrease slightly to 4.5% in the first half and remain relatively moderate at 4.2% in the second half. In the first half (H1) the market witnessed a decrease of 100 BPS while in the second half (H2), the market witnessed a decrease of 70 BPS.
Increasing Prevalence of Cardiac and Respiratory Conditions Driving the Market Growth
This rising incidence of cardiopulmonary disorders presents a major concern and, therefore, drives the need for advanced medical support such as ECMO machines. Cardiopulmonary disorders can be summed up as conditions that relate to or affect the heart and lungs-for instance, syndrome and cardiogenic shock Treatment.
In acute respiratory distress syndrome (ARDS), the small air sacs in the lungs get filled with fluid, which makes the passage of oxygen into the blood difficult. It can further progress to critical breathing problems where external support is needed to aid breathing. Cardiogenic shock is another critical condition where the heart suddenly fails to pump adequate blood to fulfill the needs of the body, thus causing organ failure if not managed quickly.
As the number of such patients increases, the demand for ECMO machines becomes even bigger. ECMO machines replace the jobs of the heart and lungs, allowing these organs to rest and recover. This technology has become integral in the intensive care unit for the treatment of patients non-responsive to other treatments. The burgeoning incidence of cardiopulmonary disorders is a prime driver for the ECMO machine industry.
Development of Portable and User-Friendly ECMO Devices creates future growth opportunity
Technological advances are revolutionizing the practice of critical care. Although lifesaving, conventional ECMO machines remain very cumbersome, and complex, and demand high specialization from a medical team to operate them.
This makes their use very difficult in large, well-prepared hospitals and results in significant complications in the implementation of ECMO support on an emergency basis or in locations with poorly developed medical infrastructure.
With these barriers, there have been efforts to develop more user-friendly and portable ECMO units. Such newer models are assumed to embody basic dimensions that are both smaller and lighter yet carry the necessary high-level functions to support severely ill patients with acute heart and lung failure.
Portable ECMO machines can be used more flexibly in several settings: patient transport, smaller hospitals, and potentially outpatient. This portability is key to making ECMO therapy more readily available, even in emergency settings when each passing moment is of vital importance.
The ease of use would enable a wider array of professionals to operate the machines with minimal specialized training. Finally, with such a surge in the availability in general of ECMO devices, patient outcomes and the more widespread acceptance of ECMO technology can be assured.
Growing Focus on Minimally Invasive ECMO Procedures
The trend toward less invasive ECMO procedures is increasing in popularity because these procedures provide patients with a much safer and more accessible treatment procedure. In such a manner, minimally invasive ECMO procedures help diminish those risks by the minimal extent of surgical invasion and application of more advanced techniques.
It technically renders a less traumatic procedure for the patient, renders shorter recovery times, and lowers the risk of complications. In such a way, a larger patient population can safely benefit from ECMO procedures. This tendency is also aimed at the wider availability of ECMO. As procedural complexities and risks are reduced, more hospitals can carry out the treatment.
This allows more access to life-saving treatment for many people, regardless of their place of residence. With the trend of healthcare providers and patients preferring less invasive options, the market for the ECMO machine is increasingly becoming sensitive to this preference by fostering innovation in and widening the adoption of cutting-edge, minimally invasive techniques in critical care.
Technological developments can hence be foreseen to lead to an extension of the role of minimally invasive ECMO as part of standard critical care.
High Cost of ECMO Machines and Procedures may restrain the Market Growth
In patients with heart or lung failure, extracorporeal membrane oxygenation is pivotal life support. That therein lies the rub-that the hundreds of thousands that ECMO machines often cost-may just well be considered one lone, major obstacle to using these wonderful machines.
This is due to advanced technology and materials used for its manufacturing. Another factor that adds to their overall cost is maintenance and operation costs related to these machines. ECMO procedures require special teams of health personnel, including surgeons, nurses, and percussionists-all adding to the overall cost of treatment.
Moreover, this price does not apply to the machine itself. The period of stay in ICUs for the patient under ECMO treatment is quite long, which increases the cost of hospitalization. This becomes unaffordable to a large number of health providers, especially those coming from more deprived areas or coming from small hospitals.
This high-cost limits access to ECMO, mostly in developing countries, raising concerns about the affordability of this life-saving technology.
The global extracorporeal membrane oxygenation machine industry recorded a CAGR of 3.8% during the historical period between 2020 and 2025. The growth of extracorporeal membrane oxygenation machine industry was positive as it reached a value of USD 944.8 million in 2035 from USD 608.4 million in 2025.
Historically, life-threatening cardiac and respiratory failures have been managed using ventilators and medications, with an extremely poor prognosis for the most severe cases. The modalities were often unable to provide adequate oxygenation, leading to extremely high mortality.
ECMO has revolutionized this approach. Unlike the traditional method, in ECMO oxygenation of the blood occurs outside the body, making it literally a lifeline for patients unresponsive to traditional treatments. In ECMO, heart and lungs are at rest, recovering and considerably improving the chances of survival in severe cases.
With the increasing incidences of critical cardiopulmonary diseases, such as acute respiratory distress syndrome, heart failure, etc. the demand for advanced life-support technologies is likely to grow. The increasing prevalence of such serious conditions, powered by factors like rapid aging and the long-lasting effects of COVID-19, is lending importance to ECMO machines in critical care.
Furthermore, due to technological advancement such as portable or user-friendly ECMO devices can further increase demand for such machines. The innovations are making ECMO more accessible, easier to use, and even easier for institutions that are further from the latest medical project technologies.
Furthermore, the growing awareness of the life-saving potential of ECMO and expanded use in the pediatric and neonatal segment is pushing up the market. The market has a boom with a continuous rise due to the inflow of investments in healthcare infrastructure and upgradation of technology with regard to ECMO.
Tier 1 companies are the industry leaders as they hold a substantial 46.6% market share worldwide. These companies have generated revenue over USD 100 million. These companies have large product portfolio and a high production capacity.
These industry leaders stand out for having a wide geographic reach, a strong customer base, and substantial experience in manufacturing. They offer a variety of product, and have a strong brand loyalty. Prominent companies within tier 1 include Medtronic, Fresenius Medical Care A.G. & Co. KGAA, Getinge Group, and Terumo Cardiovascular Systems Corporation.
Mid-size businesses with annual revenue between USD 50 and USD 100 million and which are capturing a market share of 27.7% in global market, and that are based in particular areas and have a significant impact on the local market are considered Tier 2 companies.
These companies have regional presence and in-depth industry expertise. These companies invests in newer technology and follows good manufacturing practices (GMP). These companies also collaborate with bigger companies so as to get competitive edge. Prominent companies in tier 2 include Microport, Origin Biomedical, and Nipro Corporation,
Tier 3 companies, although, smaller but are essential for the market. They have limited reach and mostly operate in few countries. They have lesser revenue as compared with tier 1 and tier 2 companies. The companies such as Livanova plc, Euro sets S.R.L., Cytosorbents Corporation, Abiomed and other falls under this category. They specialize in specific products and cater to niche markets, adding diversity to the industry.
The section below covers the industry analysis for the extracorporeal membrane oxygenation machine market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided.
The United States is anticipated to remain at the forefront in North America, with a value share of 81.6% through 2035. In Asia Pacific, China is projected to witness a CAGR of 4.5% by 2035.
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| USA | 1.4% |
| Germany | 1.4% |
| France | 2.3% |
| UK | 1.6% |
| China | 4.5% |
| India | 5.1% |
| South Korea | 3.5% |
Germany’s extracorporeal membrane oxygenation machine market is expected to exhibit a CAGR of 1.4% between 2025 and 2035. The Germany holds highest market share in European market.
The German government is making huge investments in the healthcare infrastructure, realizing new and better technology could bring about favorable patient outcomes. Part of these efforts is seen in the improvement of the critical care facilities, where part of includes putting up ECMO machines in hospitals.
The country's health policies encourage the use of frontier technologies and have even set subsidies to improve their ICU facilities. These subsidies also intend to be used for the readiness of the health workforce to ensure the efficient handling of complicated ECMO machines.
Notably, during the COVID-19 pandemic, the government of Germany gave fully fledged financial subsidies to scale ECMO capacity for the increase in critically ill respiratory cases. These steps not only support the application of ECMO machines but also spur innovation in the field and position Germany as a premier market for ECMO technology throughout Europe.
The USA market is anticipated to grow at a CAGR of 1.4% throughout the forecast period.
One major driving force behind the ECMO market in the USA is the increased rate of cardiopulmonary disorders. ARDS, COPD, and heart failure are some life-threatening conditions gaining popularity due to an aging population, increased prevalence of obesity, and lifestyle-induced diseases. Moreover, the after-effects of COVID-19 have further enhanced the prevalence of serious respiratory and cardiac disorders in USA
As these disorders grow, so does the need for advanced life-support systems like ECMO machines, which the patient requires to get crucial assistance in cases where other traditional treatments are insufficient. The USA healthcare system is, therefore, creating a surge in demand for ECMO technology in intensive care units, mainly among patients with severe cardiopulmonary failure.
This increasing demand strengthens the market growth as hospitals seek to invest in ECMO machines to enhance overall critical care competencies and improve patient outcomes.
China is expected to hold a dominating position in the East Asia market of extracorporeal membrane oxygenation machines and is anticipated to grow at a CAGR of 4.5% throughout the forecast period.
The growing adoption of ECMO in pediatric and neonatal care is one of the key drivers for the industry in China. With the country’s developing healthcare sector, more attention is paid to bettering the clinical outcomes of infants and children with life-critical cardiorespiratory diseases.
For conditions such as congenital heart defects, respiratory distress syndrome, and other serious infections in newborns; ECMO provides a lifesaving resource when conventional therapies fail.
China has been investing in specialized pediatric and neonatal intensive care units within major hospitals, and ECMO machines are finding a place as key devices. Therefore, demand in China is being fueled by the Chinese government's commitment to improving health services for children as well as by the increasing level of knowledge among healthcare professionals of ECMO's efficacy in pediatric care.
The section contains information about the leading segments in the industry. Based on product, the ECMO machines segment is expected to account for 78.5% of the global market share in 2025.
| Product | ECMO Machines |
|---|---|
| Value Share (2025) | 78.5% |
The ECMO machines segment is expected to dominate the market in terms of revenue, accounting for almost 78.5% of the market share in 2025.
The segment of ECMO machines is poised to dominate the extracorporeal membrane oxygenation market owing to its vital role in handling severe cardiac and respiratory failure. This machine gives critical life support through the oxygenation of blood outside the body, and allows both the heart and lungs of the patients to rest and recover.
Advanced capabilities are increasingly preferred in critical care due to superior support and improved survival rates. Other advancements in ECMO technologies include compact models with expanded efficiency, allowing these machines to be more appropriate and common.
Also, the rise in chronic diseases and the complexity of the needs of patients in general drive the demand for ECMO machines. Expensive as it is, the advantage this life-support machine has in sustaining patients' lives and improving recovery outcomes places it at the leading edge of market attention and underlines leadership in its segment.
| Service Type | Infrastructure |
|---|---|
| Value Share (2025) | 45.7% |
By service type, the infrastructure segment is projected to hold a major market share of 45.7% in 2025.
The infrastructure segment is anticipated to dominate due to its supporting role in installation, maintenance, and operational efficiency. This infrastructure segment includes all essential components necessary for establishing and maintaining ECMO equipment, comprising specialized facilities, technical support, and training for health professionals.
The technology behind ECMO is developing and getting more common. With increasing demand, the infrastructure of having ECMO on board-both physical and technical-is fast growing in hospitals and medical centers for proper functioning and integration.
It is assumed that, with the growing concern for advanced care and an expansion in the utilization of ECMO across different healthcare settings, the demand and importance of this segment would increase, thus leading this infrastructure segment to the front position of market forces.
The extracorporeal membrane oxygenation machine market is slightly concentrated. There are large number ECMO manufacturer in the global market involved in developing novel products so that they can meet their customer’s needs. However, the market is dominated by few top players such as Medtronic, Fresenius Medical Care A.G. & Co. KGAA, Getinge Group, and Terumo Cardiovascular Systems Corporation.
Prominent producers of extracorporeal membrane oxygenation machine products are concentrating on growing internationally in order to increase their revenue and increase the size of their sales footprint. These companies often collaborated with other research institutes to develop more advanced devices.
Manufacturers utilize various key strategies such as agreements, product launches, research sponsorship, and strategic collaborations to boost product sales and establish their market presence.
Recent Industry Developments in Extracorporeal Membrane Oxygenation Machine Market
In terms of product, the industry is divided into ECMO machines (portable devices and static devices) and software
In terms of service type, the industry is segregated into application, middleware, and infrastructure
In terms of component, the industry is divided into pumps, oxygenators, controllers, cannula, and accessories.
In terms of modality, the industry is segregated into veno-venous, veno-arterials, and arterio-venous
In terms of end user, the industry is segregated into neonates, pediatrics, and adults
Key countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.
How big is the extracorporeal membrane oxygenation machine market in 2025?
The global extracorporeal membrane oxygenation machine market is estimated to be valued at USD 608.4 million in 2025.
What will be the size of extracorporeal membrane oxygenation machine market in 2035?
The market size for the extracorporeal membrane oxygenation machine market is projected to reach USD 944.8 million by 2035.
How much will be the extracorporeal membrane oxygenation machine market growth between 2025 and 2035?
The extracorporeal membrane oxygenation machine market is expected to grow at a 4.5% CAGR between 2025 and 2035.
What are the key product types in the extracorporeal membrane oxygenation machine market?
The key product types in extracorporeal membrane oxygenation machine market are static devices, portable devices and software.
Which service type segment to contribute significant share in the extracorporeal membrane oxygenation machine market in 2025?
In terms of service type, application segment to command 50.0% share in the extracorporeal membrane oxygenation machine market in 2025.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Extracorporeal Membrane Oxygenation Machine Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
